Drug intelligence / Profile preview

benztropine

Development stage
Approved
Lead developer
USL Pharma
Modality
Small Molecules
Administration
Oral, Intramuscular, Intravenous
01

Overview

Benztropine is a synthetic anticholinergic and antihistaminic agent primarily used as an adjunct in the management of all forms of parkinsonism, including idiopathic Parkinson's disease and parkinsonism resulting from encephalitis or drug-induced extrapyramidal symptoms. Its main mechanism involves blocking muscarinic acetylcholine receptors (especially M1 subtype) in the central nervous system, particularly within the striatum, thereby restoring the balance between dopamine and acetylcholine. Benztropine also inhibits presynaptic dopamine reuptake, increasing synaptic dopamine levels, and exhibits antihistaminic activity. It is structurally related to both atropine and diphenhydramine. The drug is available as oral tablets and injectable solutions.

Brand names
Cogentin
Other names
benztropine mesylate
02

Targets

DAT (Dopamine plasma membrane transport protein)HRH1 (Histamine H1 Receptor)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)M1 (Muscarinic acetylcholine receptor M1)KCNA5 (Ultra-rapid delayed rectifier potassium channel)

Beyond the preview

Go deeper on benztropine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benztropine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call